HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kendra M Hasebroock Selected Research
Kendra M Hasebroock Research Topics
Disease
3
Neoplasms (Cancer)
02/2011 - 01/2009
2
Lupus Nephritis
01/2012 - 05/2010
1
Glomerulonephritis
01/2012
1
Lung Neoplasms (Lung Cancer)
02/2011
1
Body Weight (Weight, Body)
02/2011
1
Carcinogenesis
02/2011
1
Cysts
11/2010
1
Colorectal Neoplasms (Colorectal Cancer)
06/2010
1
Inflammation (Inflammations)
05/2010
1
Nephrogenic Fibrosing Dermopathy
04/2009
1
Prostatic Neoplasms (Prostate Cancer)
01/2009
1
Glioma (Gliomas)
01/2009
1
Breast Neoplasms (Breast Cancer)
01/2009
Drug/Important Bio-Agent (IBA)
2
Contrast Media
IBA
01/2012 - 04/2009
1
Complement C3 (C3 Complement)
IBA
01/2012
1
Biomarkers (Surrogate Marker)
IBA
01/2012
1
Complement Receptors (Complement Receptor)
IBA
01/2012
1
Silybin (Lagosa)
IBA
02/2011
1
Nestin
IBA
02/2011
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
02/2011
1
Urethane (Ethyl Carbamate)
IBA
02/2011
1
interleukin-24 (ST16)
IBA
11/2010
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
06/2010
1
Tyrosine (L-Tyrosine)
FDA Link
06/2010
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
06/2010
1
Aurora Kinase A
IBA
06/2010
1
ENMD 2076
IBA
06/2010
1
Phosphotransferases (Kinase)
IBA
06/2010
1
ferric oxide (iron oxide)
IBA
05/2010
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2009
1
Polyamines
IBA
01/2009
1
Citric Acid (Citrate)
FDA Link
Generic
01/2009
Therapy/Procedure
1
Chemoprevention
02/2011
1
Therapeutics
01/2009